Literature DB >> 24034100

Effect of endoscopic retrograde cholangiopancreatography combined with laparoscopy and choledochoscopy on the treatment of Mirizzi syndrome.

Bo Li1, Xun Li, Wen-Ce Zhou, Ming-Yan He, Wen-Bo Meng, Lei Zhang, Yu-Min Li.   

Abstract

BACKGROUND: Mirizzi syndrome is often difficult to diagnose before surgery, and is often accompanied by extensive adhesions in the cystohepatic (Calot's) triangle and the difficulty of separating tissue can lead to bile duct injury and other intraoperative and postoperative complications. The aim of this study is to investigate minimally invasive means of treating different types of Mirizzi syndrome.
METHODS: Fifty-four patients diagnosed with Mirizzi syndrome were enrolled between July 2004 and May 2012. The diagnosis was further refined according to the Csendes classification. Twenty-seven patients were treated with a combination of endoscopic retrograde cholangiopancreatography (ERCP), laparoscopy, and choledochoscopy (tripartite approach group); type I in 16 cases, type II five cases, and type III in six cases. Twenty-seven patients were treated with laparotomy (routine approach group); type I in 19 cases, type II in six cases, and type III in two cases. The operation time, blood loss during operation, initiation of intake time of food, postoperative complications, and hospital stays were compared between two groups.
RESULTS: All patients were successfully cured in surgical operation. The operation time was (49.7 ± 27.5) minutes, blood loss during operation was (21.1 ± 15.9) ml, initiation of intake time of food was (6.3 ± 2.7) hours, postoperative complications were with two cases (7%, 2/27), and hospital stay was (6.7 ± 1.8) days in the tripartite approach group. In the routine approach group, the operation time was (85.1 ± 20.3) minutes, blood loss during operation was (150.3 ± 20.5) ml, initiation of intake time of food was (36.6 ± 10.3) hours, postoperative complications were with three cases (11%, 3/27), and hospital stay was (10.9 ± 3.4) days. Except for postoperative complications, there were significant differences in the operation time, blood loss during operation, initiation of intake time of food, and hospital stays between two groups (P < 0.05).
CONCLUSIONS: ERCP combined with laparoscopy and choledochoscopy is a safe and effective means of treating Mirizzi syndrome. The approach is minimally invasive and patients recover quickly requiring only brief hospitalization.

Entities:  

Mesh:

Year:  2013        PMID: 24034100

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  5 in total

Review 1.  Updates in Mirizzi syndrome.

Authors:  Alan Isaac Valderrama-Treviño; Juan José Granados-Romero; Mariana Espejel-Deloiza; Jonathan Chernitzky-Camaño; Baltazar Barrera Mera; Aranza Guadalupe Estrada-Mata; Jesús Carlos Ceballos-Villalva; Jonathan Acuña Campos; Rubén Argüero-Sánchez
Journal:  Hepatobiliary Surg Nutr       Date:  2017-06       Impact factor: 7.293

2.  Laparoscopic approach is safe and effective in the management of Mirizzi syndrome.

Authors:  Naduthottam Palaniswami Kamalesh; Kurumboor Prakash; Kaniyarakal Pramil; Thaliyachira Deepak George; Aikot Sylesh; Ponnambathayil Shaji
Journal:  J Minim Access Surg       Date:  2015 Oct-Dec       Impact factor: 1.407

Review 3.  Current trends in the management of Mirizzi Syndrome: A review of literature.

Authors:  Hang Chen; Ernest Amos Siwo; Megan Khu; Yu Tian
Journal:  Medicine (Baltimore)       Date:  2018-01       Impact factor: 1.889

4.  Endoscopic Nasogallbladder Drainage Combined with Laparoscopic Surgery for Type I Mirizzi Syndrome with Acute Cholecystitis: A Case Series Report.

Authors:  Wei Han; Qing Yue; Kai Liu; Jian-Ji Ke; Ling-Yu Meng; Ya-Hui Liu
Journal:  Gastroenterol Res Pract       Date:  2020-04-06       Impact factor: 2.260

5.  Post-laparoscopic cholecystectomy Mirizzi syndrome induced by polymeric surgical clips: a case report and review of the literature.

Authors:  Eleni-Aikaterini Nagorni; Georgios Kouklakis; Alexandra Tsaroucha; Soultana Foutzitzi; Nikos Courcoutsakis; Konstantinos Romanidis; Konstantinos Vafiadis; Michael Pitiakoudis
Journal:  J Med Case Rep       Date:  2016-05-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.